N-nitrosodimethylamine (NDMA) and some prescribed medicines: A mini-review
Recently, there have been notices of drug recalls by different pharmaceutical companies. This is based on the finding of high level of N-nitrosodimethylamine (NDMA) in such medications. These medications are useful in the management of some diseases which affect a significant percentage of the popul...
Main Authors: | Chidiebere V Ugwueze, Chidiebele M Ezeude, Chinweuba M Abonyi, Chidimma B Nwatu, Kingsley N Ukwaja, Ekenechukwu E Young |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | International Journal of Medicine and Health Development |
Subjects: | |
Online Access: | http://www.ijmhdev.com/article.asp?issn=2635-3695;year=2022;volume=27;issue=2;spage=109;epage=113;aulast=Ugwueze |
Similar Items
-
Risk of Cancer Following the Use of N-Nitrosodimethylamine (NDMA) Contaminated Ranitidine Products: A Nationwide Cohort Study in South Korea
by: Hong Jin Yoon, et al.
Published: (2021-01-01) -
Presence of nitrosamine impurities in medicinal products
by: Sedlo Ilijana, et al.
Published: (2021-03-01) -
<i>N</i>-Nitrosodimethylamine Contamination in the Metformin Finished Products
by: Adam Zmysłowski, et al.
Published: (2020-11-01) -
Selective and sensitive GC-MS analysis of carcinogenic N-nitrosodimethylamine in pharmaceuticals using a magnetic coconut carbon composite as a solid-phase extraction sorbent
by: Hazim M. Ali, et al.
Published: (2023-12-01) -
N‐nitrosodimethylamine‐Contaminated Valsartan and Risk of Cancer: A Nationwide Study of 1.4 Million Valsartan Users
by: Imène Mansouri, et al.
Published: (2022-12-01)